Editas Medicine Inc (EDIT)
2.865
-0.04
(-1.55%)
USD |
NASDAQ |
Nov 04, 16:00
2.88
+0.02
(+0.52%)
After-Hours: 20:00
Editas Medicine Total Assets (Quarterly): 384.80M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 384.80M |
| March 31, 2024 | 440.35M |
| December 31, 2023 | 499.15M |
| September 30, 2023 | 504.65M |
| June 30, 2023 | 541.95M |
| March 31, 2023 | 464.10M |
| December 31, 2022 | 514.32M |
| September 30, 2022 | 531.03M |
| June 30, 2022 | 580.83M |
| March 31, 2022 | 623.11M |
| December 31, 2021 | 677.48M |
| September 30, 2021 | 717.02M |
| June 30, 2021 | 755.88M |
| March 31, 2021 | 780.29M |
| December 31, 2020 | 572.60M |
| September 30, 2020 | 597.16M |
| June 30, 2020 | 655.48M |
| March 31, 2020 | 466.74M |
| December 31, 2019 | 508.88M |
| Date | Value |
|---|---|
| September 30, 2019 | 372.36M |
| June 30, 2019 | 355.62M |
| March 31, 2019 | 378.92M |
| December 31, 2018 | 420.39M |
| September 30, 2018 | 387.63M |
| June 30, 2018 | 393.53M |
| March 31, 2018 | 403.98M |
| December 31, 2017 | 373.26M |
| September 30, 2017 | 339.13M |
| June 30, 2017 | 368.85M |
| March 31, 2017 | 395.04M |
| December 31, 2016 | 229.18M |
| September 30, 2016 | 242.15M |
| June 30, 2016 | 249.60M |
| March 31, 2016 | 248.81M |
| December 31, 2015 | 149.36M |
| September 30, 2015 | 159.74M |
| December 31, 2014 | 12.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
384.80M
Minimum
Jun 2024
780.29M
Maximum
Mar 2021
569.25M
Average
541.95M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 324.25M |
| Cassava Sciences Inc | 243.57M |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Vertex Pharmaceuticals Inc | 20.13B |
| Adverum Biotechnologies Inc | 253.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 152.79M |
| Shareholders Equity (Quarterly) | 232.01M |
| Current Ratio | 3.854 |